Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells

Chang Yeob Han, Kyoung Bin Cho, Hong Seok Choi, Hyo Kyung Han, Keon Wook Kang

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Abstract

The development of multidrug resistance 1 (MDR1) can be mediated by a number of different mechanisms but elevated gene expression of MDR1 (P-glycoprotein) has often been a major cause of chemoresistance in many cancer cells. Therefore, the present study aimed to investigate the role of forkhead box-containing protein, O subfamily (FoxO), transcription factors in regulating the MDR1 gene expression. The proximal promoter region of the human MDR1 contained a putative FoxO-binding site, which partially overlapped with the enhancer/enhancer-binding protein β-binding region. Gel shift and immunoblot analysis of subcellular fractions revealed that nuclear levels of FoxO1 and its DNA-binding activity were selectively enhanced in MCF-7/ADR cells, which was reversed by a FoxO1 antibody. Reporter gene assays showed that the transcription of MDR1 gene is stimulated by FoxO1 overexpression. Moreover, both MDR1 expression and doxorubicin resistance in MCF-7/ADR cells were reversed by FoxO1 small interfering RNA (siRNA). The MDR1 expression in MCF-7/ADR cells was also inhibited by insulin, a functional FoxO1 inactivator. In conclusion, FoxO1 is a novel transcriptional activator of MDR1 and is crucial for MDR1 induction in MCF-7/ADR cells.

Original languageEnglish
Pages (from-to)1837-1844
Number of pages8
JournalCarcinogenesis
Volume29
Issue number9
DOIs
StatePublished - 2008

Fingerprint

Dive into the research topics of 'Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells'. Together they form a unique fingerprint.

Cite this